Advertisement

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Business

PCAS And Nanosyn Form Production Pact

by Rick Mullin
July 27, 2009 | A version of this story appeared in Volume 87, Issue 30

PCAS, the French pharmaceutical chemical firm, and Menlo Park, Calif.-based Nanosyn have formed a pharmaceutical chemical manufacturing venture, PCAS Nanosyn. Under the agreement, PCAS will have exclusive access to a current Good Manufacturing Practice-certified plant that Nanosyn purchased from Seres Laboratories in Santa Rosa, Calif., earlier this year. According to Joseph Tessier, vice president of PCAS America, the Paris-based firm had been looking to establish a U.S. manufacturing operation, and Nanosyn, a drug discovery services firm, was looking for a partner with which to branch into full-scale pharmaceutical chemical manufacturing.

Article:

This article has been sent to the following recipient:

0 /1 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.